Skip to main content
Clinical Trials/NCT06934005
NCT06934005CompletedNot Applicable

Safety and Performance of Short- and Long-term Baseplates for Attaching the UNEEG Episight Recorder - Part II

UNEEG Medical A/S1 site in 1 country10 target enrollmentStarted: August 22, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
10
Locations
1
Primary Endpoint
Trans epidermal water loss (TEWL) to measure skin-friendliness

Study Overview

Brief Summary

The purpose of this clinical investigation is to test the safety and performance of one short- and one long-term Baseplate constructed with different types of biocompatible adhesives.

Detailed Description

This clinical investigation intended to test different biocompatible adhesives over time as part of the UNEEG Episight Baseplate construction for UNEEG™ medical A/S.

The two Baseplates reported on in this registration, is a follow-up to an initial testing of four different types of adhesive i.e., four types of Baseplates.

This study is Part II of the protocol. Part I is registered: NCT05111847

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 120 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Informed consent obtained, and letter of authority signed before any study related activities
  • •Are at least 18 years of age and have full legal capacity
  • •Healthy skin behind the ear

Exclusion Criteria

  • •Pregnant or breastfeeding
  • •Known allergic responses to the adhesives
  • •Treatment with corticosteroids, either as a cream in the area behind the ear or systemically (tablet or injection) within the last month
  • •Subject is unable or does not have the necessary assistance to properly operate the device system

Arms & Interventions

Short-term Baseplate A and long-term Baseplate C, concomitant use

Other

All participants wore Short-term Baseplate A behind one are and long-term Baseplate C behind the other ear for 35 days.

Intervention: Baseplate type C (Device)

Short-term Baseplate A and long-term Baseplate C, concomitant use

Other

All participants wore Short-term Baseplate A behind one are and long-term Baseplate C behind the other ear for 35 days.

Intervention: Baseplate type A (Device)

Outcomes

Primary Outcomes

Trans epidermal water loss (TEWL) to measure skin-friendliness

Time Frame: 35 days

To evaluate the skin barrier functionality (i.e., skin-friendliness) after repeated use of Baseplates (i.e., adhesives) on the skin behind the ear. High levels of TEWL equates to unhealthy skin = high loss of water that passes from inside a body through the epidermis.High levels of TEWL equates to unhealthy skin = high loss of water that passes from inside a body through the epidermis.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Safety and Performance of Short- and... | Clinical Trial